Personalis, Inc.

1.48 USD
-0.02 (-1.33%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Personalis, Inc. stock is down -3.27% since 30 days ago. The next earnings date is May 1, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 4 February’s closed higher than January.

About Personalis, Inc.

Personalis, Inc. operates as a cancer genomics company worldwide. It provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. The company also provides ACE platform for clinical and therapeutic applications such as neoantigen prediction, biomarker identification, and novel drug target selection.